Indications of Olaparib

1. Maintenance Treatment of Recurrent Ovarian Cancer  

Olaparib is indicated for the maintenance treatment of adult patients with recurrent epithelial ovarian,  fallopian tube or primary peritoneal cancer, who are in a complete or partial response to platinum-based  chemotherapy.  

2. Advanced gBRCA-mutated Ovarian Cancer After 3 or More Lines of Chemotherapy  

Olaparib is indicated for the treatment of adult patients with deleterious or suspected deleterious germline  BRCA-mutated (gBRCAm) advanced ovarian cancer who have been treated with three or more prior lines  of chemotherapy. Select patients for therapy based on an FDA-approved companion diagnostic for  Olaparib.

FDA,2021.08